Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-20-072065
Filing Date
2020-06-10
Accepted
2020-06-10 17:07:13
Documents
2
Group Members
CALC IV LPCITADEL ADVISORS HOLDINGS LPCITADEL GP LLCCITADEL SECURITIES GP LLCCITADEL SECURITIES LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2022318d1_sc13g.htm SC 13G 159535
2 EXHIBIT 99.1 tm2022318d1_ex99-1.htm EX-99.1 9101
  Complete submission text file 0001104659-20-072065.txt   170363
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44055 | Film No.: 20955409
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603 312-395-2100
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G